Wikidata

(Q61915528)

English

A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

short name
Protocol 102 (English)
0 references
title
A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas (English)
0 references
start time
April 2008
0 references
end time
November 2014
0 references
number of participants
58
0 references
research intervention
everolimus
0 references
sirolimus
0 references
minimum age
3 year
0 references
maximum age
75 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61915528&oldid=2164291854"